Delivery Order SPE2DB20D1110-SPE2DB24FK27J

Award Date 6/4/24
Potential Completion Date 6/5/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $89,529.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,631.76, is for the delivery of 4566914864 - LIVALO 1 MG TABLET 90S. The contract is a Firm Fixed Price Delivery Order with a completion date of January 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of pharmaceutical products, specifically Livalo 2 mg tablets, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $9,191.57, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen, with the DLA. The IDC, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,373.61 firm fixed-price delivery order is for the provision of LIVALO 1 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of December 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This contract award to AmerisourceBergen Drug Corp is a $14,381.89 firm-fixed-price delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The DLA IDC is a $999,999,999 contract vehicle that enables the federal government to efficiently procure a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. This specific...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,146.26, is for the delivery of LIVALO 2 MG TABLET 90S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of November 15, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
This federal contract award, with identification number SPE2DB20D2104|SPE2DB25FMHGJ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,959.84, is a Delivery Order for the supply of 4567140446 LIVALO 4 MG TABLET 90S. The contract is a Firm Fixed Price arrangement with a performance period ending on February 4, 2025. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $1,363.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIVALO 4 MG TABLET 90S, a pharmaceutical product, with a completion date of July 15, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, with ID SPE2DX15D2213|SPE2DX24F7X5T, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,416.12 firm fixed-price delivery order is for the supply of LIVALO 4 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of November 3, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite...
This federal contract award, with ID SPE2DB22D2103|SPE2DB24FR8RR, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,803.18 firm fixed-price delivery order is for the supply of LIVALO 4 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of December 21, 2023 and was awarded on December 20, 2023. No set-aside designation was used for this award....
  • SPE2DB20D1110
    Indefinite Delivery Contract
  • SPE2DB20D1110-SPE2DB24FK27J
    Delivery Order

This federal contract award, valued at $1,417.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of the prescription drug Livalo 1 mg tablets and does not have a set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/16/25, 12:37 PM